DHR vs NOW: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and ServiceNow, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
ServiceNow, Inc. · Technology
$139.82
+16.2% upside to fair value
Med Conviction
Grade A-
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
NOW |
| Current Price |
$221.12 |
$139.82 |
| Fair Value Estimate |
$286.52 |
$162.50 |
| Upside to Fair Value |
+29.6%
|
+16.2%
|
| Market Cap |
$155.4B |
$144.6B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
43.1x
|
| Price / Sales |
6.2x
|
9.8x
|
| Price / FCF |
28.5x
|
31.5x
|
| Revenue Growth YoY |
+5.5%
|
+24.0%
|
| Gross Margin |
58.5%
|
74.8%
|
| Operating Margin |
20.4%
|
11.4%
|
| Return on Equity |
7.7%
|
13.8%
|
| Dividend Yield |
0.65% |
0% |
| FCF Yield |
3.51%
|
3.17%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
Accumulation Zones
| Metric |
DHR |
NOW |
| Zone Low |
$214.89 |
$121.88 |
| Zone High |
$243.54 |
$138.12 |
| In Buy Zone? |
Yes
|
No
|